Transcriptional up-regulation of RhoE by hypoxia-inducible factor (HIF)-1 promotes epithelial to mesenchymal transition of gastric cancer cells during hypoxia

2011 ◽  
Vol 415 (2) ◽  
pp. 348-354 ◽  
Author(s):  
Jinfeng Zhou ◽  
Kai Li ◽  
Yong Gu ◽  
Bin Feng ◽  
Gui Ren ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Cancer Cells ◽  
Epithelial To Mesenchymal Transition ◽  
Hypoxia Inducible Factor ◽  
Gastric Cancer Cells ◽  
Mesenchymal Transition

MicroRNA-630 suppresses epithelial-to-mesenchymal transition by regulating FoxM1 in gastric cancer cells

2017 ◽  
Vol 82 (6) ◽  
pp. 707-714 ◽  
Author(s):  
Jing Feng ◽  
Xiaojuan Wang ◽  
Weihua Zhu ◽  
Si Chen ◽  
Changwei Feng
Keyword(s):  
Gastric Cancer ◽  
Cancer Cells ◽  
Epithelial To Mesenchymal Transition ◽  
Gastric Cancer Cells ◽  
Mesenchymal Transition

scholarly journals Bufalin inhibits the growth and epithelial to mesenchymal transition of human gastric cancer cells via modulation of MEK/ERK pathway

2021 ◽  
Vol 16 (1) ◽  
pp. 27-33
Author(s):  
Yi Zhou ◽  
Liguo Wang ◽  
Hui Lin ◽  
Yunxia Wang ◽  
Kezhu Hou
Keyword(s):  
Gastric Cancer ◽  
Cell Cycle ◽  
Cell Cycle Arrest ◽  
Cancer Cells ◽  
Epithelial To Mesenchymal Transition ◽  
Human Gastric Cancer ◽  
M Cell ◽  
Gastric Cancer Cells ◽  
Mesenchymal Transition ◽  
Cycle Arrest

This study was designed to evaluate the anti-cancer effects of bufalin against the human gastric cancer cells and unveil the underlying mechanism. The results showed that bufalin inhibited the proliferation and colony formation of the MGC-803 gastric cancer cells and exhibited an IC50 of 10 μM. These antiproliferative effects were found to be due to the induction of G2/M cell cycle arrest. The G2/M cell cycle arrest was also concomitant with inhibition of cdc2, cdc25 and cyclin B1. Furthermore, bufalin suppressed the epithelial-to-mesenchymal transition, migration, and invasion of the MGC-803 gastric cancer cells. The Western blot analysis revealed that bufalin exerted its effects via deactivation of EK/ERK signaling pathway. Taken together, these results suggest the potential of bufalin as the lead molecule for the development of chemotherapy for gastric cancer.  

Sign in / Sign up

Export Citation Format

Share Document